CooperCompanies Appoints Paul Keel to its Board of Directors
CooperCompanies, a Nasdaq-listed global medical device company, announced the appointment of Paul Keel, an experienced CEO in the medical device sector, to its Board of Directors effective July 1, 2026. Mr. Keel will also join the Audit Committee. His leadership experience is expected to support CooperCompanies' strategic growth and value creation.